136
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Network Pharmacology and Experimental Validation of the Anti-Inflammatory Effect of Tingli Dazao Xiefei Decoction in Acute Lung Injury Treatment

ORCID Icon, , , , , ORCID Icon & show all
Pages 6195-6209 | Received 07 Sep 2023, Accepted 12 Dec 2023, Published online: 18 Dec 2023

References

  • Yasmeen B, Anna K, Craig AT. Acute lung injury a clinical and molecular review. Arch Pathol Lab Med. 2016;140(4):345–350. doi:10.5858/arpa.2015-0519-RA
  • Erickson SE, Martin GS, Davis JL, Matthay MA, Eisner MD. Recent trends in acute lung injury mortality: 1996–2005. Crit Care Med. 2009;37(5):1574–1579. doi:10.1097/CCM.0b013e31819fefdf
  • Antoine M, Yinggang Z, Varun G, Hyungsun L, Lee JW. Mesenchymal stem cell derived secretome and extracellular vesicles for acute lung injury and other inflammatory lung diseases. Expert Opin Biol Ther. 2016;16(7):859–871. doi:10.1517/14712598.2016.1170804
  • Bellani G, Laffey JG, Pham T, et al. Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA. 2016;315(8):788–800. doi:10.1001/jama.2016.0291
  • Chyun SC, Gong MN, Hong ZR, et al. The influence of infection sites on development and mortality of ARDS. Intensive Care Med. 2010;36(6):963–970. doi:10.1007/s00134-010-1851-3
  • Mowery NT, Terzian WH, Nelson AC. Acute lung injury. Curr Probl Surg. 2020;57(5):100777. doi:10.1016/j.cpsurg.2020.100777
  • Jesús V, Carlos F, Domingo M, et al. Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial. Lancet Respir Med. 2020;8(3):267–276. doi:10.1016/s2213-2600(19)30417-5
  • Rong C, Chen C, Huimin L, et al. Macrophage Sprouty4 deficiency diminishes sepsis-induced acute lung injury in mice. Redox Biol. 2022;58:102513. doi:10.1016/j.redox.2022.102513
  • Patel VJ, Biswas Roy S, Mehta HJ, Joo M, Sadikot RT. Alternative and natural therapies for acute lung injury and acute respiratory distress syndrome. BioMed Res Int. 2018;2018:2476824. doi:10.1155/2018/2476824
  • Yinpin D. The applied value analysis of Tingli Dazao Xiefei decoction and Sanzi yangqin decoction on pulmonary heart disease. Cardiovasc Dis Electron J Integr Tradit Chin West Med. 2019;7(17):147–148. Chinese. doi:10.16282/j.cnki.cn11-9336/r.2019.17.120
  • Min X. Efficacy of the Tingli Dazao Xiefei decoction on ARDS caused by pulmonary contusion. Clin J Chin Med. 2018;10(8):19–21. Chinese. doi:10.3969/j.issn.1674-7860.2018.08.008
  • Wenjing W. Effect of tingli dazao xiefei decoction on pulmonary function and inflammation in patients with lung abscess. Guangming J Chin Med. 2022;37(19):3533–3535. Chinese. doi:10.3969/j.issn.1003-8914.2022.19.024
  • Kelei S, Xingjiang X. Treatment strategy and thought on classical herbal formulae for coronavirus disease 2019. Chin J Chin Mater Med. 2021;46(2):494–503. doi:10.19540/j.cnki.cjcmm.20200603.501
  • Xu L, Yan C, Xuesong B, et al. Research progress on the mechanism of traditional Chinese medicine treatment of acute lung injury / acute respiratory distress syndrome. J Liaoning Univ Tradit Chin Med. 2017;19(1):166–170. Chinese. doi:10.13194/j.issn.1673-842x.2017.01.049
  • Jinghua L, Wangxiao T, Siwei W, Yu W, Xiaoying W. Study on the mechanism of Tingli Dazao Xiefei decoction in the treatment of COVID-19 based on the network pharmacology. Shandong Sci. 2020;33(5):1–13. Chinese. doi:10.3976/j.issn.1002-4026.2020.05.001
  • Liang L, Lina W, Lei W, et al. Mechanism action of Tingli Dazao Xiefei Tang in the treatment of children with pneumonia based on network pharmacology. J Pediatr Tradit Chin Med. 2021;17(1):8–13. Chinese. doi:10.16840/j.issn1673-4297.2021.01.03
  • Qian L, Fengxia S, Yun M, et al. Based on network pharmacology and molecular docking technology to explore the mechanism of tingli dazao xiefei decoction in the treatment of chronic pulmonary heart disease. Res Pract Chin Med. 2021;35(06):33–39. Chinese. doi:10.13728/j.1673-6427.2021.06.008
  • Jiaqi Y, Yifan M, Yumei Z, et al. Dao-chi powder ameliorates pancreatitis-induced intestinal and cardiac injuries via regulating the Nrf2-HO-1-HMGB1 signaling pathway in rats. Front Pharmacol. 2022;13:922130. doi:10.3389/fphar.2022.922130
  • Jinlong R, Peng L, Jinan W, et al. TCMSP: a database of systems pharmacology for drug discovery from herbal medicines. J Cheminf. 2014;6(13):6. 13. doi:10.1186/1758-2946-6-13
  • Zhongyang L, Feifei G, Yong W, et al. BATMAN-TCM: a bioinformatics analysis tool for molecular mechANism of Traditional Chinese medicine. Sci Rep. 2016;6:21146. doi:10.1038/srep21146
  • Fan Y. Canker sores in the lungs. In: Medical Treasures of the Golden Chamber. Chin press Tradit Chin Med; 2003:117.
  • Xinguo W. Basic knowledge of pharmacological experimental design in Chinese medicine. In: Pharmacology of Chinese Medicine Experimental Course. Chin press Tradit Chin Med; 2017:8.
  • Yuan R, Peipei Y, Panying L, et al. Tingli Dazao Xiefei Decoction ameliorates asthma in vivo and in vitro from lung to intestine by modifying NO–CO metabolic disorder mediated inflammation, immune imbalance, cellular barrier damage, oxidative stress and intestinal bacterial disorders. J Ethnopharmacol. 2023;313:116503. doi:10.1016/j.jep.2023.116503
  • Beibei Z, Mengnan Z, Qinqin Z, et al. Effects of Tingli Dazao Xiefei decoction on the immune inflammation and intestinal flora in asthmatic rats. Acta Pharm Sin. 2022;57(8):2364–2377. Chinese. doi:10.16438/j.0513-4870.2022-0116
  • Nolan T, Hands RE, Bustin SA. Quantification of mRNA using real-time RT-PCR. Nat Protoc. 2006;1(3):1559–1582. doi:10.1038/nprot.2006.236
  • Xiaoqian L, Cong S, Zhonghua W, Hongji Y, Aidong Y, Bo T. Emodin alleviated pulmonary inflammation in rats with LPS-induced acute lung injury through inhibiting the mTOR/HIF-1 alpha/VEGF signaling pathway. Inflamm Res. 2020;69(4):365–373. doi:10.1007/s00011-020-01331-3
  • Hongxia Z. Clinical observation on wuhu decoction combined with Tingli Dazao Xiefei decoction in treating mycoplasma pneumonia in children of phlegm-heatobstructing the lung type. Pract Clin J Integr Tradit Chin West Med. 2021;21(13):104–105. Chinese. doi:10.13638/j.issn.1671-4040.2021.13.051
  • Lian L, Jiangbo T, Weijun H, Yang L. Clinical observation on wuhu decoction combined with Tingli Dazao Xiefei decoction in treating bronchial pneumonia in children of phlegm-heatobstructing the lung type. Chin Med Mod Distance Educ Chin. 2022;20(16):96–98. Chinese. doi:10.3969/j.issn.1672-2779.2022.16.036
  • Xiaohui X. Efficacy of modified Tingli Dazao Xiefei decoction in treating bronchial asthma and evaluation of patients’ adverse reactions. Contemp Med. 2022;28(6):7–10. Chinese. doi:10.3969/j.issn.1009-4393.2022.06.003
  • Yufeng S, Fanxiao K, Chunsheng F. Efficacy observation of modified Zhenwu Decoction and Tingli Dazao Xiefei Decoction on pneumoconiosis. Chin J Mod Drug Appl. 2022;16(12):147–150. Chinese. doi:10.14164/j.cnki.cn11-5581/r.2022.12.048
  • Kejing Y, Zhixin Q. Clinical observation on treatment of acute respiratory distress syndrome caused by lung contusion with modified Tingli Dazao Xiefei decoction. J Emerg Tradit Chin Med. 2016;25(5):878–880. Chinese. doi:10.3969/j.issn.1673-7202.2016.09.016
  • Qin MZ, Qin MB, Liang ZH, Tang GD. Effect of SOCS3 on lung injury in rats with severe acute pancreatitis through regulating JAK2/STAT3 signaling pathway. Riv Eur Sci Med Farmacol. 2019;23(22):10123–10131. doi:10.26355/eurrev_201911_19582
  • Xiao H, Yuxi W, Hailong C, et al. Enhancement of ICAM-1 via the JAK2/STAT3 signaling pathway in a rat model of severe acute pancreatitis-associated lung injury. Exp Ther Med. 2016;11(3):788–796. doi:10.3892/etm.2016.2988
  • Caixia L, Yuhong L, Han Z, et al. Xuanfei Baidu Decoction suppresses complement overactivation and ameliorates IgG immune complex-induced acute lung injury by inhibiting JAK2/STAT3/SOCS3 and NF-Kappa B signaling pathway. Phytomedicine. 2023;109:154551. doi:10.1016/j.phymed.2022.154551
  • Shuiqiao F, Weina L, Wenqia Y, Jun H. Protective effect of Cordyceps sinensis extract on lipopolysaccharide-induced acute lung injury in mice. Biosci Rep. 2019;39(6):Bsr20190789. doi:10.1042/bsr20190789
  • Huahe Z, Shun W, Cong S, et al. Mechanism of protective effect of xuan-bai-cheng-qi decoction on LPS-induced acute lung injury based on an integrated network pharmacology and RNA-sequencing approach. Respir Res. 2021;22(1):188. doi:10.1186/s12931-021-01781-1
  • Yanru W, Xiaojie J, Qin F, et al. Deciphering the active compounds and mechanisms of HSBDF for Treating ALI via integrating chemical bioinformatics analysis. Front Pharmacol. 2022;13:879268. doi:10.3389/fphar.2022.879268
  • Daxue H, Shengquan W, Gaofeng F, et al. LXRs/ABCA1 activation contribute to the anti-inflammatory role of phytosterols on LPS-induced acute lung injury. J Funct Foods. 2022;89:104966. doi:10.1016/j.jff.2022.104966
  • Ruihua Z, Xia A, Yongjie D, et al. Kaempferol ameliorates H9N2 swine influenza virus-induced acute lung injury by inactivation of TLR4/MyD88-mediated NF-kappa B and MAPK signaling pathways. Biomed Pharmacother. 2017;89:660–672. doi:10.1016/j.biopha.2017.02.081